Naltrexone Therapy for Crohn’s Disease and Ulcerative Colitis
Journal of Clinical Gastroenterology
A relatively unknown approach to inflammatory bowel disease is the use of low dose naltrexone. Reports of naltrexone for Crohn’s disease first started in 2007 from Pennsylvania State University. As with any Crohn’s disease therapy it is rare to get more than 70% efficacy from any medicine since there are many pathways for inflammation. The same is true for ulcerative colitis treatment. Includes an article that was published in 2014 in the Journal of Clinical Gastroenterology that provides detailed information how naltrexone works in inflammatory bowel disease and what was found in the author's practice in both ulcerative colitis and Crohn's disease.